SMARCC1 is a susceptibility gene for congenital hydrocephalus with an autosomal dominant inheritance mode and incomplete penetrance.


Journal

Prenatal diagnosis
ISSN: 1097-0223
Titre abrégé: Prenat Diagn
Pays: England
ID NLM: 8106540

Informations de publication

Date de publication:
09 2023
Historique:
revised: 10 08 2023
received: 25 06 2023
accepted: 13 08 2023
medline: 14 9 2023
pubmed: 28 8 2023
entrez: 28 8 2023
Statut: ppublish

Résumé

A Jewish couple of mixed origin was referred for genetic counseling following termination of pregnancy at 18 weeks of gestation due to severe ventriculomegaly with aqueduct stenosis. Trio exome sequencing revealed a loss-of-function heterozygous variant in the SMARCC1 gene inherited from an unaffected mother. The SMARCC1 gene is associated with embryonic neurodevelopmental processes. Recent studies have linked perturbations of the gene with autosomal dominant congenital hydrocephalus, albeit with reduced penetrance. However, these studies were not referenced in the SMARCC1 OMIM record (*601732) and the gene was not considered, at the time, an OMIM morbid gene. Following our case and appeal, SMARCC1 is now considered a susceptibility gene for hydrocephalus. This allowed us to reclassify the variant as likely pathogenic and empowered the couple to make informed reproductive choices.

Identifiants

pubmed: 37639281
doi: 10.1002/pd.6426
doi:

Substances chimiques

SMARCC1 protein, human 0
Transcription Factors 0

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

1374-1377

Informations de copyright

© 2023 The Authors. Prenatal Diagnosis published by John Wiley & Sons Ltd.

Références

Yaron Y, Ofen Glassner V, Mory A, et al. Exome sequencing as a first-tier test for fetuses with severe central nervous system structural anomalies. Ultrasound Obstet Gynecol. 2022;60(1):59-67. https://doi.org/10.1002/uog.24885
Furey CG, Choi J, Jin SC, et al. De novo mutation in genes regulating neural stem cell fate in human congenital hydrocephalus. Neuron. 2018;99(2):302-314, e304. https://doi.org/10.1016/j.neuron.2018.06.019
Jin SC, Dong W, Kundishora AJ, et al. Exome sequencing implicates genetic disruption of prenatal neuro-gliogenesis in sporadic congenital hydrocephalus. Nat Med. 2020;26(11):1754-1765. https://doi.org/10.1038/s41591-020-1090-2
Harmacek L, Watkins-Chow DE, Chen J, et al. A unique missense allele of BAF155, a core BAF chromatin remodeling complex protein, causes neural tube closure defects in mice. Dev Neurobiol. 2014;74(5):483-497. https://doi.org/10.1002/dneu.22142
Al Mutairi F, Alzahrani F, Ababneh F, Kashgari AA, Alkuraya FS. A mendelian form of neural tube defect caused by a de novo null variant in SMARCC1 in an identical twin. Ann Neurol. 2018;83(2):433-436. https://doi.org/10.1002/ana.25152
Hydrocephalus, Congenital, 5, Susceptibility to; HYC5. OMIM; 2023. Accessed March 7, 2023. https://omim.org/entry/620241
Le Gouard NR, Nicolle R, Lefebvre M, et al. First reports of fetal SMARCC1 related hydrocephalus. Eur J Med Genet. 2023;66(8):104797. https://doi.org/10.1016/j.ejmg.2023.104797

Auteurs

Noa Hourvitz (N)

The Genetics Institute and Genomics Center, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.

Alina Kurolap (A)

The Genetics Institute and Genomics Center, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.

Adi Mory (A)

The Genetics Institute and Genomics Center, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.

Karina Krajden Haratz (KK)

Division of Ultrasound in Obstetrics and Gynecology, Lis Maternity and Hospital for Women's Health, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Dvora Kidron (D)

Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Department of Pathology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.

Gustavo Malinger (G)

Division of Ultrasound in Obstetrics and Gynecology, Lis Maternity and Hospital for Women's Health, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Hagit Baris Feldman (H)

The Genetics Institute and Genomics Center, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Yuval Yaron (Y)

The Genetics Institute and Genomics Center, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH